New Insights into Optic Nerve Injury Treatment with Brain-Derived Neurotrophic Factor (BDNF)
In the article “Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush,” published in Pharmaceuticals, Volume 17, Issue 6 (June 2024), scientists explored the impact of BDNF on retinal structure and visual function. The study focused on rodent models to investigate how BDNF affects retinal ganglion cell (RGC) survival and ganglion cell complex thickness. The results demonstrated that BDNF significantly enhances RGC survival and thickness, highlighting its potential as a neuroprotective treatment for optic neuropathies.
EyeCRO scientists contributed to this important research, demonstrating our ongoing commitment to advancing ophthalmic science and developing innovative treatments for vision-related conditions.
Read the full article here.